Navigation Links
Cancer Experts, Patients, and Families Meet for Local Blood Cancer Conference
Date:5/11/2017

Myeloproliferative Neoplasms (MPNs) are a family of related blood cancers in which the individuals bone marrow makes too many red blood cells, white blood cells, or platelets. The most common forms of MPNs are polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF) and chronic myeloid leukemia (CML).

Local cancer organizations have come together to help healthcare providers, patients, and families dealing with MPNs. The fourth annual Spring to Life Conference on Hematologic Malignancies, sponsored by New York Oncology Hematology, will be held at the Albany Marriott Hotel, Albany, NY on Saturday, May 20, 2017, from 7:30 am – 3:15 pm.

This one-day CME-certified conference will bring together healthcare professionals and members of the community—including patients, survivors, family members, and caregivers—to gain an up-to-date understanding of blood cancers, including the state-of-the-art science behind treatment, clinical management, ongoing translational research, and emerging therapies.

“Our Spring to Life conference each year highlights a different focus in the broad spectrum of hematologic malignancies or blood cancers and brings regional expertise to our community,” explains Ira Zackon, MD, New York Oncology Hematology and Conference Chair and Moderator. “Continued education at the local community level is critical to maintaining the highest quality and leading edge of health care. This year’s conference highlights this in particular, in focusing on less common diseases that do not get as much attention. Similarly, our afternoon session this year for patients, families, and community is focused on the Caregiver, the partner in health and life who also can receive less attention. These afternoon sessions continue to gain in reputation as meaningful and impactful engagements on living through the cancer experience.”    

The 2017 conference will focus on myeloproliferative neoplasms (MPNs), including presentations from those touched by cancer; as well as experts from New York Oncology Hematology, PC (NYOH) Albany Medical College, the Dana-Farber Cancer Institute, and Harvard Medical School.

“At Leukemia & Lymphoma Society (LLS) our mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families," said Jennifer McGarry, Leukemia & Lymphoma Society Director, Patient Access Volunteer Development. “The Spring To Life Conference on Hematologic Malignancies provides a wonderful opportunity for patients and caregivers to come together, share their experiences, and work together to improve care.”

The event is divided into two, half-day sessions:

  • Professional program (7:30 AM ? 12:30 PM): The morning program focuses on the most recent research, clinical management, and emerging therapies for MPNs. These sessions are designed to meet the educational needs of primary care practitioners, hematologists, oncologists, pediatricians, allied health professionals (including nurses, pharmacists, and social workers), and basic scientists.
  • Community session: (12:30 PM ? 3:15 PM): The afternoon session is designed to benefit patients with MPNs, as well as their families, companions, and caregivers. Patients and their loved ones will join health care experts, community oncologist/hematologists, and social workers to share stories and improve understanding in a supportive environment.

The symposium is hosted by New York Oncology Hematology, the region’s largest provider of community cancer care. It is accredited by Center for Emergency Medical Education (CEME) for 3.75 AMA PRA Category 1 Credits ™. The Oncology Nursing Society (ONS) will award 3.75 contact hours (based on a 60-minute contact hour) to registered nurses who complete the educational activity.

Conference attendees will enjoy complimentary breakfast, light lunch, and snacks, as well as opportunities to view exhibitor displays.

There is no fee for this educational activity. For more information or to register, visit: http://www.spring2lifeheme.org.

***

About New York Oncology Hematology
New York Oncology Hematology (NYOH) is the region’s leading provider of community-based cancer care and services. With seven convenient locations, a team of 36 physicians, and more than 300 oncology professionals, NYOH has been delivering world-class cancer care to the Capital Region and surrounding communities for more than 30 years. Through its affiliation with The US Oncology Network, one of the nation’s largest cancer treatment and research networks, NYOH offers the latest breakthroughs, treatments, and technologies – right here at home.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. The Upstate NY/VT Chapter is located in Albany, NY.

Read the full story at http://www.prweb.com/releases/2017/05/prweb14319235.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Diet Doc’s Prescription Hormone Diets & Weight Loss Plans Announces New Clean Eating Diet Plans to Slim the Waistline While Reducing the Risk for Colorectal Cancer
2. Water Select® Raises Funds for Teen with Deadly Brain Cancer Known as Glioblastoma
3. Tree nut consumption associated with reduced risk of pancreatic cancer in women
4. Robots from space lead to 1-stop breast cancer diagnosis treatment
5. Online course improves physicians skill level for detecting skin cancer
6. AACR to host Annual Conference on Science of Cancer Health Disparities
7. Scientists at Cancer Prevention Institute of California Find That a Diet High in Fruits and Vegetables May Significantly Reduce Risk of Breast Cancer
8. Potential for added medical benefits uncovered for widely used breast cancer drug
9. UT Southwestern researchers discover a new driver of breast cancer
10. Hope builds for a drug that might shut down a variety of cancers
11. Mayo Clinic: Less-invasive option as effective as esophagus removal in early esophageal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... MA (PRWEB) , ... May 26, 2017 , ... On ... Act (AHCA), which narrowly passed the U.S. House on May 4, would result in ... be expected under continued implementation of the 2010 Patient Protection and Affordable Care Act ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant ... of published author Laura Weigel Douglas, an avid reader who lives in the Pacific ... sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year ...
(Date:5/26/2017)... ... ... Happened in the Garden of Eden”: retells the stories of three Bible figures in modern ... author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. Born ... At six, they moved to Dayton, Ohio, where Penny graduated high school. At sixteen, ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... Medical Center CEO Mary Ellen, hospital employees, and town officials to celebrate the ... The facility was developed by Rendina as part of its ongoing relationship with ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data analytics ... 2017 ranking of the Best-Equipped Hospitals in Latin America ... GHI,s hospitals database for Latin America , which is ... database covers 86% of the hospitals in Latin ... each institution in key areas such as beds, medical specialties, ...
Breaking Medicine Technology: